O'Neill Louisa, De Becker Benjamin, De Smet Maarten, Le Polain De Waroux Jean-Benoit, Tavernier Rene, Duytschaever Mattias, Knecht Sebastien
Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium.
Front Cardiovasc Med. 2022 Dec 7;9:1073239. doi: 10.3389/fcvm.2022.1073239. eCollection 2022.
Recurrent atrial tachycardia (AT) is a common phenomenon after catheter ablation for AF, particularly in the setting of additional substrate ablation, with many studies demonstrating gap-related macro re-entrant AT (predominantly mitral and roof dependent) to be the dominant mechanism. Although multiple inducible ATs after ablation of the clinical AT are commonly described at repeat procedures, the optimal ablation strategy, and procedural endpoints are unclear in this setting. A recent randomized study addressing the question of non-inducibility as a procedural endpoint demonstrated no additional benefits to the ablation of all induced, non-clinical ATs, but it was limited by small numbers and high rates of non-inducibility. Nevertheless, once ablation of the clinical AT has been successfully performed, ensuring durable linear block and PV isolation may be sufficient for the prevention of further AT. Durable linear block, particularly at the mitral isthmus, is difficult to achieve but may be facilitated by the real-time evaluation of lesion quality and contiguity and the novel technique of vein of Marshall ethanol infusion. Large-scale, randomized trials are needed, nonetheless, to fully assess the optimal ablation strategy in the setting of recurrent AT post-AF ablation.
复发性房性心动过速(AT)是房颤导管消融术后的常见现象,尤其是在进行额外基质消融的情况下,许多研究表明与间隙相关的大折返性AT(主要依赖二尖瓣和房顶)是主要机制。尽管在重复手术中通常会描述在临床AT消融后出现多种可诱发的AT,但在这种情况下,最佳消融策略和手术终点尚不清楚。最近一项针对将不可诱发性作为手术终点问题的随机研究表明,消融所有诱发的非临床AT并无额外益处,但该研究受样本量小和不可诱发性发生率高的限制。尽管如此,一旦成功完成临床AT的消融,确保持久的线性阻滞和肺静脉隔离可能足以预防进一步的AT。持久的线性阻滞很难实现,尤其是在二尖瓣峡部,但通过实时评估病变质量和连续性以及Marshall静脉乙醇注射新技术可能会有所帮助。然而,仍需要大规模随机试验来全面评估房颤消融术后复发性AT情况下的最佳消融策略。